Bonobol
Bonobol Uses, Dosage, Side Effects, Food Interaction and all others data.
Bonobol Phenylpropionate is an injectable anabolic preparation. The pharmacologically active substance is nandrolone. The phenylpropionate ester gives the preparation a duration of action of about one week after injection. Bonobol is chemically related to the male hormone. Compared to testosterone, it has an enhanced anabolic and a reduced androgenic activity. This has been demonstrated in animal bioassays and explained by receptor binding studies. The low androgenicity of nandrolone is confirmed in clinical use.In the human, Bonobol Phenylpropionate has a nitrogen saving action. This effect on protein metabolism has been established by metabolic studies and is utilized therapeutically in conditions where a protein deficiency exists such as during chronic debilitating diseases and after major surgery and severe trauma. In these conditions, Bonobol Phenylpropionate serves as a supportive adjunct to specific therapies and dietary measures. In women with disseminated mammary carcinoma, in selected cases Bonobol Phenylpropionate has been reported to produce objective regressions for many months. Furthermore, Bonobol Phenylpropionate has been shown to produce relief of bone pain in patients with osteoporosis. The similarly acting nandrolone ester, nandrolone decanoate, has been shown to increase bone mineral content in these patients. Androgenic effects (e.g. virilisation) are relatively uncommon at the recommended dosages. Bonobol lacks the C17alpha-alkyl group which is associated with the occurrence of liver dysfunction and cholestasis.
Trade Name | Bonobol |
Availability | Discontinued |
Generic | Nandrolone |
Nandrolone Other Names | 19-norandrostenolone, 19-nortestosterone, Nandrolona, Nandrolone, Nandrolonum |
Related Drugs | ferrous sulfate, Arimidex, Ibrance, Femara, Xeloda, Herceptin, Aranesp, Epogen, epoetin alfa |
Type | Injection |
Formula | C18H26O2 |
Weight | Average: 274.3978 Monoisotopic: 274.193280076 |
Groups | Experimental, Investigational |
Therapeutic Class | Anabolic steroid (Androgens), Hormone in bone formation by stimulation |
Manufacturer | Ultramark Pharmaceuticals |
Available Country | India |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Bonobol Phenylpropionate is used-
- As an adjunct to specific therapies and dietary measures in pathologic conditions characterized by a negative nitrogen balance
- For the palliative treatment of selected cases of disseminated mammary carcinoma in women
- Osteoporosis.
Bonobol is also used to associated treatment for these conditions: Osteoporosis (Senile), Osteoporosis caused by glucocorticoid
Dosage
Bonobol dosage
As an adjunct to specific therapies and dietary measures in pathologic conditions characterized by a negative nitrogen balance: Recommended dose is 25-50 mg every week.
For the palliative treatment of selected cases of disseminated mammary carcinoma in women: Recommended dose is 50 mg every week.
Osteoporosis: Recommended dose is 50 mg every week.
For an optimal therapeutic effect it is necessary to administer adequate amounts of vitamins, minerals and protein in a calorie-rich diet. Bonobol Phenylpropionate should be administered by deep intramuscular injection.
Side Effects
High dosages, prolonged treatment and/or too frequent administration may cause:
- Virilisation which appears in sensitive women as hoarseness, acne hirsutism and increase of libido; in prepubertal boys as an increased frequency of erections and phallic enlargement, and in girls as an increase of pubic hair and clitoral hypertrophy. Hoarseness may be the first symptom of vocal change which may end in a long-lasting, sometimes irreversible deepening of the voice.
- Amenorrhoea.
- Inhibition of spermatogenesis.
- Premature epiphyseal closure.
- Fluid retention.
Precaution
If signs of virilisation develop, discontinuation of the treatment should be considered, Preferably in consultation with the patient.
It is recommended to monitor patients with any of the following conditions:
- latent or overt cardiac failure, renal dysfunction, hypertension or migraine (or a history of these conditions), since anabolic steroids may occasioally induce fluid retention:
- incomplete statural growth, since anabolic steroids in high dosages may accelerate epiphyseal closure;
- skeletal metastases of breast carcinoma. In these patients
- hypercalcaemia may develop both spontaneously and as a result of anabolic steroid therapy. The later can be indicative of a positive tumour response to the hormonal treatment. Nevertheless, the hypercalcaemia should first be treated appropriately and after restoration of normal calcium levels hormone therapy can be resumed;
- liver dysfunction.
Interaction
Anabolic steroids may improve glucose tolerance and decrease the need for insulin or other antidiabetic medicines in diabetics.
Bonobol Cholesterol interaction
[Major] Androgenic anabolic steroids may adversely affect serum lipids, including lowering HDL and elevating LDL levels.
These changes can be marked, particularly with the 17-alpha-alkyl derivatives (i.e., fluoxymesterone, methyltestosterone, oxandrolone, oxymetholone, and stanozolol), and may significantly impact the risk of atherosclerosis and coronary artery disease.
Patients with preexisting hyperlipoproteinemia may require closer monitoring during therapy with androgenic agents, and adjustments made accordingly in their lipid-lowering regimen.
Androgen therapy should be administered cautiously in patients with coronary artery disease or a history of ischemic heart disease.
Bonobol Drug Interaction
Moderate: thyroid desiccatedUnknown: amphetamine / dextroamphetamine, zolpidem, anastrozole, aspirin, tadalafil, testosterone, chorionic gonadotropin , sodium iodide, arginine, acetaminophen, quetiapine, valacyclovir, cyanocobalamin, pyridoxine, cholecalciferol, phytonadione, bupropion, alprazolam, zinc sulfate
Pregnancy & Breastfeeding use
This medicine is contraindicated during pregnancy because of possible masculinization of the foetus. There are insufficient data on the use of this medicine during breast-feeding to assess potential harm to the infant or a possible influence on milk production.
Contraindication
Contraindicated in Pregnancy, Known or suspected carcinoma of the prostate or breast in the male.
Acute Overdose
The acute toxicity of Bonobol Phenylpropionate in animals is very low. There are no reports of acute overdosage with Bonobol Phenylpropionate in the human
Storage Condition
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Innovators Monograph
You find simplified version here Bonobol